PRECISVIEW Trademark

Trademark Overview


On Friday, March 2, 2018, a trademark application was filed for PRECISVIEW with the United States Patent and Trademark Office. The USPTO has given the PRECISVIEW trademark a serial number of 87818515. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Wednesday, September 3, 2025. This trademark is owned by Sano Informed Prescribing, Inc.. The PRECISVIEW trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Scientific and technological services featuring testing, analysis and evaluation of blood samples for the purpose of drug development by others, namely, data-driven analytics and reporting to developers of drugs; scientific and technological services featuring testing, analysis and evaluation of blood samples for the purpose of improving quality in the field of healthcare services, specifically for improving the monitoring and diagnostics of quantitative patient drug exposure, monitoring and diagnostics of patient drug compliance, data-driven analytics and reporting to providers of healthcare services in the field of pharmacovigilance activities, drug dosage recommendations, initial drug prescribing, and drug switching, all for research purposes and not for medical purposes
precisview

General Information


Serial Number87818515
Word MarkPRECISVIEW
Filing DateFriday, March 2, 2018
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateWednesday, September 3, 2025
Registration Number5807807
Registration DateTuesday, July 16, 2019
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, July 31, 2018

Trademark Statements


Description of MarkThe mark consists of one word, "PRECISVIEW", beginning with a capital "P" and a punctuation mark over the first "I" as it appears in the word followed by a capital "V" for the word "VIEW".
Pseudo MarkPRECIS VIEW
Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and ServicesScientific and technological services featuring testing, analysis and evaluation of blood samples for the purpose of drug development by others, namely, data-driven analytics and reporting to developers of drugs; scientific and technological services featuring testing, analysis and evaluation of blood samples for the purpose of improving quality in the field of healthcare services, specifically for improving the monitoring and diagnostics of quantitative patient drug exposure, monitoring and diagnostics of patient drug compliance, data-driven analytics and reporting to providers of healthcare services in the field of pharmacovigilance activities, drug dosage recommendations, initial drug prescribing, and drug switching, all for research purposes and not for medical purposes

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, March 9, 2018
Primary Code042
First Use Anywhere DateMonday, March 25, 2019
First Use In Commerce DateMonday, March 25, 2019

Trademark Owner History


Party NamePHENOMICS HEALTH INC.
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressPlymouth, MI 48170

Party NamePRECERA BIOSCIENCE, INC.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressFRANKLIN, TN 37067

Party NamePRECERA BIOSCIENCE, INC.
Party Type21 - New Owner After Publication
Legal Entity Type03 - Corporation
AddressFRANKLIN, TN 37067

Party NameSano Informed Prescribing, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressFranklin, TN 37067

Party NameSano Informed Prescribing, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressFranklin, TN 37067

Trademark Events


Event DateEvent Description
Tuesday, March 6, 2018NEW APPLICATION ENTERED
Friday, March 9, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, June 14, 2018EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED
Thursday, June 14, 2018EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
Thursday, June 14, 2018NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
Friday, June 15, 2018COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION ENTERED
Monday, June 25, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, March 10, 2018NOTICE OF DESIGN SEARCH CODE E-MAILED
Thursday, June 14, 2018ASSIGNED TO EXAMINER
Friday, June 15, 2018ASSIGNED TO LIE
Monday, June 25, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, June 26, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, July 11, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 9, 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, June 27, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, July 4, 2018ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Tuesday, July 31, 2018PUBLISHED FOR OPPOSITION
Tuesday, July 31, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 25, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, March 25, 2019TEAS STATEMENT OF USE RECEIVED
Monday, March 25, 2019USE AMENDMENT FILED
Wednesday, June 12, 2019STATEMENT OF USE PROCESSING COMPLETE
Tuesday, July 16, 2019REGISTERED-PRINCIPAL REGISTER
Wednesday, September 25, 2019AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Thursday, June 13, 2019ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Friday, June 14, 2019NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Wednesday, October 2, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, October 2, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, September 3, 2025CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Wednesday, September 3, 2025REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Wednesday, September 3, 2025NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Friday, April 25, 2025TEAS SECTION 8 & 15 RECEIVED
Tuesday, July 16, 2024COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED